TER Systematic Research
Systematic screening highlights Teradyne as an exceptional profitability case trading at elevated multiples following substantial recent appreciation. The semiconductor test equipment manufacturer demonstrates a ROE of 29.72% and ROA of 20.9%, reflecting capital-efficient operations in a specialized market segment. The current valuation framework shows a P/E ratio of 88.07 and P/S ratio of 19.86, pricing in significant growth expectations after the stock surged near its 52-week high of $472.37 from a base of $88.60.
The fundamental profile reveals compelling operational momentum, with revenue growth of 30.32% year-over-year and EPS expansion of 52.94%. Net margin efficiency at 22.55% indicates pricing power and operational leverage in its test solutions portfolio. The balance sheet structure displays conservative financial management with a debt-to-equity ratio of just 0.07 and a current ratio of 1.75, providing flexibility for strategic capital deployment across research initiatives and potential market downturns.
Key analytical considerations include:
- Multiple expansion risk: The 88.07x trailing earnings multiple embeds substantial execution requirements relative to semiconductor equipment cyclicality
- Beta of 1.75 signals amplified sensitivity to broader technology sector volatility
- Book value per share of $17.91 against a $483.84 price point produces the 10.84x P/B ratio, reflecting intangible asset concentration
Relative to peers AMAT, LRCX, and KLAC, the research perspective indicates Teradyne occupies a differentiated position in automated test equipment versus deposition and inspection tools, with profitability metrics supporting its premium valuation architecture within semiconductor capital equipment positioning.
Analysis updated monthly based on systematic screening of fundamentals, profitability, growth, and peer positioning.